SUMMARY When 17 patients with Sjogren's syndrome, without apparent clinical manifestations of renal disease, were examined renal function studies frequently indicated abnormalities in their renal phosphate handling. The percentage tubular reabsorption of phosphate (%TRP) was decreased in six (35-3%), and maximal tubular reabsorption rate for phosphate (TmPO4/GFR) was low in eight (47.1%). In contrast, indices of renal calcium handling and serum parathyroid hormone levels were normal, suggesting that the abnormalities of phosphate metabolism were due not to extrinsic, but rather to intrinsic disease processes occurring in the kidney in Sjogren's syndrome. When the patients were divided into two groups according to the presence or absence of a renal tubular acidification defect (RTAD), patients with RTAD were younger (p<0-005), had longer disease duration (p<O-O1), lower creatinine clearance (p<0-05), and higher incidence of low %TRP (p<O0O5). Thus the patients with lower creatinine clearance generally had disease of longer duration at diagnosis and tended also to have defects in concentrating and acidifying the urine.
Sjogren's syndrome is sometimes associated with renal tubular acidosis -7 or tubular concentrating defect.' 7-1"( Tu et al have pointed out the pathological similarity between the lesion in the salivary gland and in the kidney,'1 suggesting that the lesion in interstitial nephritis, consisting of lymphoid cellular infiltration, 6 ll could be part of the multiple organ-system infiltration characteristic of Sjogren's syndrome.
We have analysed renal function in patients with Sjogren's syndrome, particularly noting their renal handling of phosphate and circulating levels of parathyroid hormone (PTH). In addition, we have sought inter-relationships between different parameters of renal function in the hope of obtaining greater insight than would be possible by analysing each parameter individually.
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Patients and methods

PATIENTS
Medical records of all inpatients with Sjogren's syndrome admitted between 1979 and 1985 were reviewed. In addition, two patients (Nos 6 and 11) were included from our outpatient clinic. Patients were excluded if the diagnostic criteria described below were not fulfilled. Patients were also excluded if adequate data were not available to assess renal function; thus 17 were selected out of a total of 22 patients ( Table 1 18 To determine NH4Cl loading, ammonium chloride was given at 0*1 g/kg body weight, and urine was collected at the start and at hourly intervals for six hours. Urine pH determinations were carried out within 30 min of voiding. Diagnosis of renal tubular acidification defect (RTAD) was made when the urine pH did not fall below pH 5-3 in any of the specimens.5 Plasma parathyroid hormone (PTH) was measured by radioimmunoassay using antibody recognising the C terminal 1-34 .portion of the molecule (C-PTH) (Eiken Chemicals Co, Tokyo, Japan). Blood samples for plasma PTH measurement were obtained in the outpatient clinic. Bone histology on the iliac crest bone biopsy specimen was evaluated as described previously. ' . 
Discussion
The results show that renal function was considerably defective in the patients with Sjogren's syndrome even when they were without apparent clinical manifestations of renal disease. The abnormalities were not confined to distal tubules, but proximal tubules were also, though less frequently, involved. This finding confirms previous results on the renal tubular acidosis or tubular concentrating defects observed in Sjogren's syndrome, -lo and shows that there is no selectivity in the anatomical site of involvement in the kidney of Sjogren's syndrome. It was found that, although indices of renal handling of phosphate such as %TRP or TmPO4/ GFR were frequently abnormal, indices of calcium metabolism and serum PTH levels were both normal. This would indicate that the abnormalities of phosphate metabolism seen in these patients were not due to extrinsic hormonal control, but were caused by an intrinsic pathological process within the kidney. These findings are thus compatible with previous pathological results which showed that interstitial nephritis with lymphoid cellular infiltration is the main lesion in the kidney in Sjogren's syndrome. 5 6 The present results show that among the various parameters of renal function urine concentrating ability is most vulnerable to damage in Sjogren's syndrome. This was observed irrespective of whether the patients had RTAD or not. It thus appeared that renal concentrating ability was primarily involved during the course of the disease and thus could be a sensitive indicator of renal damage in Sjogren's syndrome.
It was observed that the patients with lower creatinine clearance values generally had disease of longer duration at diagnosis; and tended also to be unable to concentrate and acidify the urine, indicating that a selective mechanism of injury directed specifically at the renal tubular acidification system is not present. Instead, it is likely that renal tubular acidosis is the result of an extension of a generalised pathological process within the kidney. Our results are compatible with the conclusion that the abnormalities of renal function, such as those observed with regard to phosphate metabolism, are due not to extrinsic, but rather to an intrinsic disease process in the kidney. The present results thus support the previous pathological finding that interstitial nephritis with lymphoid cellular infiltration is the main lesion in the kidney in Sjogren's syndrome. It is likely that the local injuries in the kidney and in the salivary gland have a similar basis, as proposed by Tu et al. 1 If this is the case, it may be predicted from these and other studies that renal involvement in Sjogren's syndrome is reversible depending on the stage of the disease process or on the treatment. 
